Disambiguation evidence for tislelizumab via surface form
"tislelizumab"
Triples (2)
Triples where some other subject referred to this entity
as "tislelizumab".
Disambiguation evidence for tislelizumab via surface form
Triples where some other subject referred to this entity
as "tislelizumab".